Insider Transactions in Q4 2023 at Keros Therapeutics, Inc. (KROS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 04
2023
|
Keith Regnante CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
40,000
-100.0%
|
$1,800,000
$45.29 P/Share
|
|
Nov 04
2023
|
Keith Regnante CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+50.0%
|
$640,000
$16.0 P/Share
|